ESCRS - Supplement: New Medical Therapies and Modern MIGs Address Unmet Needs in Galucoma and Cataract Patient Care
Supplements

Supplement: New Medical Therapies and Modern MIGs Address Unmet Needs in Galucoma and Cataract Patient Care

Supplement: New Medical Therapies and Modern MIGs Address Unmet Needs in Galucoma and Cataract Patient Care

According to the 2020 ESCRS Clinical Trends Survey, an average of 21% of patients prescribed one or two topical glaucoma medications and 27% of those prescribed more than two topical glaucoma medications to control their condition are not compliant (Figure 1). It is a significant number of patients.

Tags: glaucoma
Latest Articles
Committing to a More Equitable Ophthalmology

Charity Committee enhances ESCRS’s reputation as a socially responsible society.

Read more...

Virtual Community Unites Ukrainian Eye Specialists

Microlearning platform proves vital to saving eyes and lives in areas of conflict.

Read more...

ESCRS Survey Shifts Industry Dial

Annual survey reveals trends and issues regarding the digital OR.

Read more...

Always Measure the Epithelium!

Epithelium thickness mapping key to better refractive outcomes.

Read more...

Brave New World of AI

More applications for anterior segment anticipated.

Read more...

Advancing Vision Research

National Eye Institute initiatives encourage AI-based innovations and data interoperability.

Read more...

Best Candidates for Phakic EDOF IOLs?

Patient profile suggests limits for phakic EDOF approach.

Read more...

Knowing Iris Repair: Iris Repair with Prosthetic Devices

New devices on the market expand available options when iris tissue is insufficient.

Read more...

Targeting the Kallikrein-Kinin System to Treat DME

Novel oral plasma kallikrein inhibitor shows promise in early clinical trial.

Read more...

Faricimab VOYAGER Study

Real-world experience with faricimab for treatment-naïve nAMD and DME is underway.

Read more...